Akintunde Olatokumbo Bello - 10 Jun 2025 Form 3 Insider Report for Xilio Therapeutics, Inc. (XLO)

Role
Director
Signature
/s/ Elana Brockmann, Attorney-in-Fact
Issuer symbol
XLO
Transactions as of
10 Jun 2025
Net transactions value
$0
Form type
3
Filing time
12 Jun 2025, 16:33:58 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Bello Akintunde Olatokumbo Director 828 WINTER STREET, SUITE 300, WALTHAM /s/ Elana Brockmann, Attorney-in-Fact 12 Jun 2025 0002070709

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney